These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 33647366
1. Discontinuation of oral anticoagulation and risk of stroke and death after ablation for typical atrial flutter: A nation-wide Danish cohort study. Giehm-Reese M, Johansen MN, Kronborg MB, Jensen HK, Gerdes C, Kristensen J, Johannessen A, Jacobsen PK, Djurhuus MS, Hansen PS, Riahi S, Nielsen JC. Int J Cardiol; 2021 Jun 15; 333():110-116. PubMed ID: 33647366 [Abstract] [Full Text] [Related]
2. Recurrent atrial flutter ablation and incidence of atrial fibrillation ablation after first-time ablation for typical atrial flutter: A nation-wide Danish cohort study. Giehm-Reese M, Kronborg MB, Lukac P, Kristiansen SB, Nielsen JM, Johannessen A, Jacobsen PK, Djurhuus MS, Riahi S, Hansen PS, Nielsen JC. Int J Cardiol; 2020 Jan 01; 298():44-51. PubMed ID: 31521436 [Abstract] [Full Text] [Related]
3. Current Status and Clinical Outcomes of Oral Anticoagulant Discontinuation After Ablation for Atrial Fibrillation in Japan - Findings From the AF Frontier Ablation Registry. Okumura Y, Nagashima K, Arai M, Watanabe R, Yokoyama K, Matsumoto N, Otsuka T, Suzuki S, Hirata A, Murakami M, Takami M, Kimura M, Fukaya H, Nakahara S, Kato T, Shimizu W, Iwasaki YK, Hayashi H, Harada T, Nakajima I, Okumura K, Koyama J, Tokuda M, Yamane T, Momiyama Y, Tanimoto K, Soejima K, Nonoguchi N, Ejima K, Hagiwara N, Harada M, Sonoda K, Inoue M, Kumagai K, Hayashi H, Satomi K, Yazaki Y, Watari Y, AF Ablation Frontier Registry. Circ J; 2019 Nov 25; 83(12):2418-2427. PubMed ID: 31619591 [Abstract] [Full Text] [Related]
4. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation. Freeman JV, Shrader P, Pieper KS, Allen LA, Chan PS, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel JA, Singer DE, Go AS, Hylek EM, Steinberg BA, Peterson ED, Piccini JP. Circ Arrhythm Electrophysiol; 2019 Dec 25; 12(12):e007612. PubMed ID: 31830822 [Abstract] [Full Text] [Related]
5. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation. Noseworthy PA, Yao X, Deshmukh AJ, Van Houten H, Sangaralingham LR, Siontis KC, Piccini JP, Asirvatham SJ, Friedman PA, Packer DL, Gersh BJ, Shah ND. J Am Heart Assoc; 2015 Nov 05; 4(11):. PubMed ID: 26541393 [Abstract] [Full Text] [Related]
6. Clinical outcomes of solitary atrial flutter patients using anticoagulation therapy: a national cohort study. Chen YL, Lin YS, Wang HT, Liu WH, Chen HC, Chen MC. Europace; 2019 Feb 01; 21(2):313-321. PubMed ID: 30107472 [Abstract] [Full Text] [Related]
7. Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for atrial flutter. Celikyurt U, Knecht S, Kuehne M, Reichlin T, Muehl A, Spies F, Osswald S, Sticherling C. Europace; 2017 Nov 01; 19(11):1776-1780. PubMed ID: 28069839 [Abstract] [Full Text] [Related]
8. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients. Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA. Europace; 2014 Feb 01; 16(2):195-201. PubMed ID: 24036378 [Abstract] [Full Text] [Related]
9. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ. Heart Rhythm; 2015 Apr 01; 12(4):681-6. PubMed ID: 25546809 [Abstract] [Full Text] [Related]
10. Risk of atrial fibrillation after atrial flutter ablation: impact of AF history, gender, and antiarrhythmic drug medication. Brembilla-Perrot B, Girerd N, Sellal JM, Olivier A, Manenti V, Villemin T, Beurrier D, DE Chillou C, Louis P, Selton O, DE LA Chaise AT. J Cardiovasc Electrophysiol; 2014 Aug 01; 25(8):813-820. PubMed ID: 24654647 [Abstract] [Full Text] [Related]
11. Incidence and patterns of atrial fibrillation after catheter ablation of typical atrial flutter-the FLUTFIB study. Attanasio P, Budde T, Kamieniarz P, Tscholl V, Nagel P, Biewener S, Parwani A, Boldt LH, Landmesser U, Hindricks G, Huemer M. Europace; 2024 Feb 01; 26(2):. PubMed ID: 38302192 [Abstract] [Full Text] [Related]
12. Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes. Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA. J Interv Card Electrophysiol; 2013 Dec 01; 38(3):147-53. PubMed ID: 24101149 [Abstract] [Full Text] [Related]
13. Typical atrial flutter but not fibrillation predicts coronary artery disease in formerly healthy patients. Iden L, Richardt G, Weinert R, Groschke S, Toelg R, Borlich M. Europace; 2021 Aug 06; 23(8):1227-1236. PubMed ID: 33611584 [Abstract] [Full Text] [Related]
14. The safety of discontinuation of oral anticoagulation therapy after apparently successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry study. Yang WY, Du X, Jiang C, He L, Fawzy AM, Wang L, Liu C, Xia SJ, Chang SS, Guo XY, Li SN, Tang RB, Liu N, Bai R, Sang CH, Jiang CX, Yu RH, Long DY, Dong JZ, Lip GYH, Ma CS. Europace; 2020 Jan 01; 22(1):90-99. PubMed ID: 31909431 [Abstract] [Full Text] [Related]
15. The implications of catheter ablation for solitary atrial flutter in preventing stroke risk: a nationwide population-based cohort study. Lin YS, Wu VC, Wang HT, Chen HC, Chen MC, Chang ST, Chu PH, Chen YL. Europace; 2020 Oct 01; 22(10):1558-1566. PubMed ID: 32830229 [Abstract] [Full Text] [Related]
16. Comparison of Clinical Outcomes Among Patients With Atrial Fibrillation or Atrial Flutter Stratified by CHA2DS2-VASc Score. Lin YS, Chen YL, Chen TH, Lin MS, Liu CH, Yang TY, Chung CM, Chen MC. JAMA Netw Open; 2018 Aug 03; 1(4):e180941. PubMed ID: 30646091 [Abstract] [Full Text] [Related]
17. Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS2 to the CHA2DS2-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation Registry. Katz DF, Maddox TM, Turakhia M, Gehi A, O'Brien EC, Lubitz SA, Turchin A, Doros G, Lei L, Varosy P, Marzec L, Hsu JC. Circ Cardiovasc Qual Outcomes; 2017 May 03; 10(5):. PubMed ID: 28506981 [Abstract] [Full Text] [Related]
18. Continuous rhythm monitoring-guided anticoagulation after atrial fibrillation ablation. Pothineni NVK, Amankwah N, Santangeli P, Schaller RD, Supple GE, Deo R, Nazarian S, Garcia FC, Dixit S, Callans DJ, Marchlinski FE, Frankel DS. J Cardiovasc Electrophysiol; 2021 Feb 03; 32(2):345-353. PubMed ID: 33382500 [Abstract] [Full Text] [Related]
19. Atrial fibrillation inducibility during cavotricuspid isthmus-dependent atrial flutter ablation as a predictor of clinical atrial fibrillation. A meta-analysis. Romero J, Diaz JC, Di Biase L, Kumar S, Briceno D, Tedrow UB, Valencia CR, Baldinger SH, Koplan B, Epstein LM, John R, Michaud GF, Stevenson WG. J Interv Card Electrophysiol; 2017 Apr 03; 48(3):307-315. PubMed ID: 28070875 [Abstract] [Full Text] [Related]
20. Factors Influencing Oral Anticoagulation Prescription for Patients Presenting to Emergency Departments With Atrial Fibrillation and Flutter. Miller RJH, Chew DS, Rezazadeh S, Klassen S, Pournazari P, Lang E, Quinn FR. Can J Cardiol; 2018 Jun 03; 34(6):804-807. PubMed ID: 29801744 [Abstract] [Full Text] [Related] Page: [Next] [New Search]